NO973531L - Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet - Google Patents

Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet

Info

Publication number: NO973531L
Authority: NO; Norway
Prior art keywords: melatonin; treatment; patients suffering; drug addiction; addiction
Prior art date: 1995-02-01

Application number

NO973531A

Other languages

English (en)

Other versions

NO973531D0 (no

NO312814B1 (no

Inventor

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-01

Filing date

1997-07-31

Publication date

1997-09-30

1995-02-01 Priority claimed from US08/381,535 external-priority patent/US6469044B1/en

1997-07-31 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

1997-07-31 Publication of NO973531D0 publication Critical patent/NO973531D0/no

1997-09-30 Publication of NO973531L publication Critical patent/NO973531L/no

2002-07-08 Publication of NO312814B1 publication Critical patent/NO312814B1/no

Links

YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
206010013663 drug dependence Diseases 0.000 title 1
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
229960003987 melatonin Drugs 0.000 title 1
208000011117 substance-related disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO19973531A 1995-02-01 1997-07-31 Anvendelse av melatonin ved fremstilling av et medikament for behandling av pasienter som lider av medikamentavhengighet NO312814B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/381,535 US6469044B1 (en)	1995-02-01	1995-02-01	Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en)	1995-02-01	1995-06-06	Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en)	1995-02-01	1996-01-29	Use of melatonin for treating patients suffering from drug addiction

Publications (3)

Publication Number	Publication Date
NO973531D0 NO973531D0 (no)	1997-07-31
NO973531L true NO973531L (no)	1997-09-30
NO312814B1 NO312814B1 (no)	2002-07-08

Family

ID=26140195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19973531A NO312814B1 (no)	1995-02-01	1997-07-31	Anvendelse av melatonin ved fremstilling av et medikament for behandling av pasienter som lider av medikamentavhengighet

Country Status (22)

Country	Link
JP (1)	JP4516159B2 (no)
CN (1)	CN1083263C (no)
AT (1)	AT408188B (no)
AU (1)	AU695366B2 (no)
BG (1)	BG62876B1 (no)
BR (1)	BR9607169A (no)
CZ (1)	CZ291349B6 (no)
DK (1)	DK176081B1 (no)
EE (1)	EE03384B1 (no)
FI (1)	FI119586B (no)
IS (1)	IS1980B (no)
LU (1)	LU90118B1 (no)
LV (1)	LV11940B (no)
MD (1)	MD1716C2 (no)
NO (1)	NO312814B1 (no)
NZ (1)	NZ298878A (no)
PL (1)	PL183148B1 (no)
SI (1)	SI9620022A (no)
SK (1)	SK284521B6 (no)
TR (1)	TR199700723T1 (no)
TW (1)	TW483757B (no)
WO (1)	WO1996023496A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL150190A0 (en)	2000-01-05	2002-12-01	Neurim Pharma 1991	Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) *	2002-04-28	2012-10-31	Neurim Pharma 1991	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en)	2003-04-29	2013-12-31	Neurim Pharma 1991	Insomnia treatment
US9119846B2 (en)	2003-04-29	2015-09-01	Neurim Pharmaceuticals (1991) Ltd.	Method and composition for enhancing cognition in alzheimer's patients
IL330095A (en)	2012-01-26	2026-08-01	Vanda Pharmaceuticals Inc	Tesimalta for use in the treatment of asynchronous circadian rhythm of cortisol
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
IL266159B2 (en)	2012-12-18	2024-07-01	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
DK3337462T3 (da) *	2016-10-31	2020-10-12	Neurim Pharma 1991	Melatonin-minitabletter og fremgangsmåde til fremstilling heraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69229490T2 (de) *	1991-05-09	2000-02-17	Neurim Pharmaceuticals (1991) Ltd., Tel Aviv	Melatonin enthaltende Arzneimittel
IT1251544B (it) *	1991-05-13	1995-05-17	Gabriele Biella	Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

1996
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active

Also Published As

Publication number	Publication date
PL183148B1 (pl)	2002-05-31
CZ240597A3 (cs)	1998-01-14
BR9607169A (pt)	1997-11-11
MD1716C2 (ro)	2002-02-28
PL321630A1 (en)	1997-12-08
EE9700166A (et)	1998-02-16
ATA901396A (de)	2001-02-15
JP4516159B2 (ja)	2010-08-04
SK284521B6 (sk)	2005-05-05
FI973185A0 (fi)	1997-07-31
MD970254A (en)	1999-05-31
SI9620022A (sl)	1998-10-31
TW483757B (en)	2002-04-21
TR199700723T1 (xx)	1998-02-21
EE03384B1 (et)	2001-04-16
NZ298878A (en)	1999-05-28
IS1980B (is)	2005-01-14
DK89697A (da)	1997-07-30
MX9705856A (es)	1998-07-31
AU4457496A (en)	1996-08-21
FI119586B (fi)	2009-01-15
SK103097A3 (en)	1998-01-14
JPH10513177A (ja)	1998-12-15
CN1083263C (zh)	2002-04-24
BG101803A (en)	1998-04-30
WO1996023496A1 (en)	1996-08-08
CZ291349B6 (cs)	2003-02-12
CN1172431A (zh)	1998-02-04
LV11940A (lv)	1998-01-20
AT408188B (de)	2001-09-25
MD1716B2 (en)	2001-08-31
LV11940B (en)	1998-05-20
FI973185L (fi)	1997-09-30
DK176081B1 (da)	2006-04-18
AU695366B2 (en)	1998-08-13
IS4532A (is)	1997-07-25
NO973531D0 (no)	1997-07-31
NO312814B1 (no)	2002-07-08
BG62876B1 (bg)	2000-10-31
LU90118B1 (fr)	1997-11-13

Legal Events

Date	Code	Title	Description
2016-02-08	MK1K	Patent expired

Publication	Publication Date	Title
NO976063D0 (no)	1997-12-23	Fremgangsmåte for behandling av diabetes
NO965377L (no)	1997-02-12	Indolinonforbindelser for behandling av sykdommer
NO982172D0 (no)	1998-05-13	Anvendelse av epinastin for behandling av smerter
CY2007001I1 (el)	2009-11-04	Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
LT97135A (en)	1997-12-29	Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction
DE69620691D1 (de)	2002-05-23	Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO973531D0 (no)	1997-07-31	Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
NO20003229D0 (no)	2000-06-21	Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
NO975545D0 (no)	1997-12-02	Cellelinje som produserer analgetiske forbindelser for behandling av smerte
FI973023L (fi)	1997-07-16	Liikakasvusairauksien yhdistetty terapeuttinen hoito
NO975660D0 (no)	1997-12-05	Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
IS4528A (is)	1997-07-21	Bísýklískar afleiður ísóþíóþvagefnis nothæfar viðlæknismeðferð
NO995231D0 (no)	1999-10-26	Terapeutisk behandling av hudlidelser
AU7291996A (en)	1997-05-15	Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
FI971527A7 (fi)	1997-04-11	Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO20012106D0 (no)	2001-04-27	Middel for behandling av benpatobolisme
NO973081D0 (no)	1997-07-02	Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
NO994258L (no)	1999-11-02	Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO20014812L (no)	2001-10-03	Fremgangsmate for tilveiebringelse av kosmetisk/medisinsk terapi
NO981822L (no)	1998-04-23	Anvendelse av proteinet GAX for behandling av cancer
NO982562D0 (no)	1998-06-04	Sammensetning for behandling av smerte
NO973366D0 (no)	1997-07-21	Fremgangsmåte for behandling av multippel sklerose
DE69840432D1 (de)	2009-02-26	Arzneimittel zur behandlung der augen
NO974529D0 (no)	1997-09-30	Innretning for tilförselen av alfuzosin gjennom huden
NO20001894L (no)	2000-04-12	Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer